Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.
SK Mahil 
;
ZZN Yiu ;
KJ Mason ;
N Dand;
B Coker;
D Wall;
G Fletcher;
A Bosma;
F Capon ;
L Iversen ;
+13 more...
SM Langan ;
P Di Meglio;
AH Musters;
D Prieto-Merino ;
T Tsakok;
RB Warren;
C Flohr ;
PI Spuls;
CEM Griffiths;
J Barker;
AD Irvine ;
CH Smith;
Secure-AD and PsoProtect study groups;
(2020)
Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.
British Journal of Dermatology, 183 (2).
pp. 404-406.
ISSN 0007-0963
DOI: 10.1111/bjd.19161
;
ZZN Yiu ;
KJ Mason ;
N Dand;
B Coker;
D Wall;
G Fletcher;
A Bosma;
F Capon ;
L Iversen ;
+13 more...
SM Langan ;
P Di Meglio;
AH Musters;
D Prieto-Merino ;
T Tsakok;
RB Warren;
C Flohr ;
PI Spuls;
CEM Griffiths;
J Barker;
AD Irvine ;
CH Smith;
Secure-AD and PsoProtect study groups;
(2020)
Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.
British Journal of Dermatology, 183 (2).
pp. 404-406.
ISSN 0007-0963
DOI: 10.1111/bjd.19161
We wish to bring your attention to the PsoPROTECT (Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of Covid-19 infecTion) and SECURE-AD (Surveillance Epidemiology of Coronavirus Under Research Exclusion-Atopic Dermatitis) registries; two urgent global initiatives that address an unmet need for delineating the determinants of COVID-19 outcomes in the common cutaneous immune-mediated inflammatory diseases (IMIDs) psoriasis and atopic dermatitis.
-
picture_as_pdf - bjd.19161.pdf
-
subject - Accepted Version
-
- Available under Creative Commons: NC-ND 3.0
Downloads